The Impact of COVID-19 on Pharmaceutical Shortages and Supply Disruptions for Non-Communicable Diseases Among Public Hospitals of South West, Oromia, Ethiopia

References

• Goodarzian F, Taleizadeh AA, Ghasemi P, Abraham A. An integrated sustainable medical supply chain network during COVID-19. Eng Appl Artif Intell. 2021;100:104188. doi:10.1016/j.engappai.2021.104188
   PubMed Web of Science ®Google Scholar
• Romano S, Galante H, Figueira D, Mendes Z, Rodrigues AT. Time-trend analysis of medicine sales and shortages during COVID-19 outbreak: data from community pharmacies. Res Social Adm Pharm. 2021;17(1):1876–1881. doi:10.1016/j.sapharm.2020.05.024
   PubMed Web of Science ®Google Scholar
• World Health Organization. The world health report 2002: reducing risks, promoting healthy life. World Health Organization; 2002.
   Google Scholar
• Cameron A, Ewen M, Auton M, Abegunde D. The World Medicines Situation 2011. Medicines Prices, Availability and Affordability. World Health Organization; Vol. 3, 2011.
   Google Scholar
• Aruru M, Truong H-A, Clark S. Pharmacy Emergency Preparedness and Response (PEPR): a proposed framework for expanding pharmacy professionals’ roles and contributions to emergency preparedness and response during the COVID-19 pandemic and beyond. Res Social Adm Pharm. 2021;17(1):1967–1977. doi:10.1016/j.sapharm.2020.04.002
   PubMed Web of Science ®Google Scholar
• Goodarzian F, Navaei A, Ehsani B, Ghasemi P, Muñuzuri J. Designing an integrated responsive-green-cold vaccine supply chain network using Internet-of-Things: artificial intelligence-based solutions. Ann Oper Res. 2022;1–45. doi:10.1007/s10479-022-04713-4
   PubMed Web of Science ®Google Scholar
• Goodarzian F, Ghasemi P, Gunasekaren A, Taleizadeh AA, Abraham A. A sustainable-resilience healthcare network for handling COVID-19 pandemic. Ann Oper Res. 2022;312(2):761–825. doi:10.1007/s10479-021-04238-2
   PubMed Web of Science ®Google Scholar
• Bigdeli M, Laing R, Tomson G, Babar Z-U-D. Medicines and universal health coverage: challenges and opportunities. J Pharm Policy Pract. 2015;1–3. doi:10.1186/s40545-014-0024-0
   PubMedGoogle Scholar
• Georgiou N, Delfabbro P, Balzan R. COVID-19-related conspiracy beliefs and their relationship with perceived stress and pre-existing conspiracy beliefs. Pers Individ Dif. 2020;166:110201. doi:10.1016/j.paid.2020.110201
   PubMed Web of Science ®Google Scholar
• Edozieuno A. Assessment of anti-malaria logistic management system performance at primary health care level in Oyo state, Nigeria; 2012.
   Google Scholar
• Yimenu DK, Demeke CA, Kasahun AE, et al. Impact of COVID-19 on pharmaceutical care services and the role of community pharmacists: a multi-center cross-sectional study in Ethiopia. SAGE Open Nurs. 2021;7:23779608211025804. doi:10.1177/23779608211025804
   Web of Science ®Google Scholar
• Sheppard J, Thomas CB. Community pharmacists and communication in the time of COVID-19: applying the health belief model. Res Social Adm Pharm. 2021;17(1):1984–1987. doi:10.1016/j.sapharm.2020.03.017
   PubMed Web of Science ®Google Scholar
• Hill A. Ways to safeguard UK drug supplies during COVID-19 and beyond. Pharmaceut J. 2020;304:7936.
   Google Scholar
• Hossain MS, Ferdous S, Siddiqee MH. Mass panic during Covid-19 outbreak-A perspective from Bangladesh as a high-risk country. J Biomed Anal. 2020;3(2):1–3. doi:10.30577/jba.v3i2.40
   Google Scholar
• Salahuddin M, Manzar D, Unissa A, Pandi-Perumal SR, BaHammam AS. The global shortage of essential drugs during the COVID-19 pandemic: evidence based on aggregated media and social media reports. J Nat Sci Med. 2022;5(1):23.
   Google Scholar
• Kebede Y, Birhanu Z, Fufa D, et al. Myths, beliefs, and perceptions about COVID-19 in Ethiopia: a need to address information gaps and enable combating efforts. PLoS One. 2020;15(11):e0243024. doi:10.1371/journal.pone.0243024
   PubMed Web of Science ®Google Scholar
• Kassie BA, Adane A, Tilahun YT, Kassahun EA, Ayele AS, Belew AK. Knowledge and attitude towards COVID-19 and associated factors among health care providers in Northwest Ethiopia. PLoS One. 2020;15(8):e0238415. doi:10.1371/journal.pone.0238415
   PubMed Web of Science ®Google Scholar
• AlRuthia YS, AlKofide H, AlAjmi R, et al. Drug shortages in large hospitals in Riyadh: a cross-sectional study. Ann Saudi Med. 2017;37(5):375–385. doi:10.5144/0256-4947.2017.375
   PubMed Web of Science ®Google Scholar
• Consortium WST. Repurposed antiviral drugs for Covid-19—interim WHO solidarity trial results. N Engl J Med. 2021;384(6):497–511.
   PubMed Web of Science ®Google Scholar
• Kefale AT, Shebo HH. Availability of essential medicines and pharmaceutical inventory management practice at health centers of Adama town, Ethiopia. BMC Health Serv Res. 2019;19(1):1–7. doi:10.1186/s12913-019-4087-0
   PubMed Web of Science ®Google Scholar
• Aronovich DG, Kinzett S. Kenya: Assessment of the Health Commodity Supply Chains and the Role of KEMSA. VA, Arlington: John Snow, Inc; 2001.
   Google Scholar
• Fentie M, Fenta A, Moges F, et al. Availability of essential medicines and inventory management practice in primary public health facilities of Gondar town, north West Ethiopia. J PharmaSciTech. 2015;4(2):54–56.
   Google Scholar
• Asemahagn MA, Alene GD, Yimer SA. A qualitative insight into barriers to tuberculosis case detection in East Gojjam Zone, Ethiopia. Am J Trop Med Hyg. 2020;103(4):1455. doi:10.4269/ajtmh.20-0050
   PubMed Web of Science ®Google Scholar
• Tumwine Y, Kutyabami P, Odoi RA, Kalyango JN. Availability and expiry of essential medicines and supplies during the ‘pull’and ‘push’drug acquisition systems in a rural Ugandan hospital. Trop J Pharm Res. 2010;9(6):3.
   Web of Science ®Google Scholar
• Uganda M. Pharmaceutical situation assessment, level II, health facilities survey in Uganda. Ministry of Health; 2008.
   Google Scholar
• Ahmed M. Diabetic foot disease and its management. World Fam Med. 2020;18(12):242–247.
   Web of Science ®Google Scholar
• Zheng S-Q, Yang L, Zhou P-X, Li H-B, Liu F, Zhao R-S. Recommendations and guidance for providing pharmaceutical care services during COVID-19 pandemic: a China perspective. Res Social Adm Pharm. 2021;17(1):1819–1824. doi:10.1016/j.sapharm.2020.03.012
   PubMed Web of Science ®Google Scholar